5-Bromo-3-(Trifluoromethyl)-2-Pyridinecarbonitrile

We are 5-Bromo-3-(Trifluoromethyl)-2-Pyridinecarbonitrile CAS:1214377-57-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  5-Bromo-3-(Trifluoromethyl)-2-Pyridinecarbonitrile
CAS.NO: 1214377-57-7
Synonyms:5-bromo-3-(trifluoromethyl)pyridine-2-carbonitrile;
5-Bromo-2-cyano-3-(trifluoromethyl)pyridine;
Molecular Formula:  C7H2BrF3N2
Molecular Weight: 251.00300
 
Physical and Chemical Properties:
Density: 1.81g/cm3
Melting point: /
Boiling point: 257ºC
Flash point:  110ºC
Index of Refraction:1.517
 
Specification:
Appearance:  White Crystalline Powder
Purity:≥99.0%
 
Packing:25kg/drum
Storage:Store in a tightly closed container. Store in a cool, dry.
Application:     used in the Pharmaceutical Industrial

5-Bromo-3-(Trifluoromethyl)-2-Pyridinecarbonitrile


Related News: The technology supports breakthroughs in medical research and is widely used by major global pharmaceutical companies to advance drug discovery & development and provide data to support regulatory submissions.9-bromo-1-nonanol CAS:55362-80-6 Raw material drug manufacturing is listed as one of the top ten key remediation industries, and it is necessary to implement clean transformation, new construction, reconstruction, and expansion of the ten key remediation industry construction projects to implement equal or reduced emissions of major pollutants; ) The industry implements the green enzyme production technology transformation; at the same time, the ten articles of water classify the industrial discharged sewage, and the sewage discharge of API companies is restricted.2,2,3,3,3-pentafluoropropan-1-amina CAS:422-03-7 The company’s iPSC product platform unites stem cell biology and precision genetic engineering to create renewable master engineered iPSC lines that can be repeatedly used to mass produce cancer-fighting immune cells, replacing the high production costs, weeks of manufacturing time, and complex engineering processes required for current-generation CAR T-cell immunotherapies with an off-the-shelf product that has the potential to reach many more patients.4-(Trifluoromethoxy)benzenesulfonamide Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System.With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.

Related Products
Product Name
4,6-bis(difluoromethoxy)pyrimidin-2-amine View Details
2,7-Dihydroxynaphthalene View Details
octamethylcyclotetrasiloxane View Details
1-Bromo-3-iodobenzene manufacturer Trans-4-Pentylcyclohexanecarboxylic Acid Cas:38289-29-1 manufacturer 2′-deoxy-2′-fluoro-2′-C-methyluridine Cas:863329-66-2 manufacturer 2,4-Difluoronitrobenzene manufacturer 6-Hydroxy-2-naphthaldehyde Cas:78119-82-1 manufacturer